tykhr
sign in
free sign up
Regeneron Pharmaceuticals Inc
Biotechnology
Healthcare
REGN
111 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
580.00
52 week high
1164.46
high
582.00
52 week low
0.00
low
565.45
growth
-50.40 %
previous Close
595.68
P/E ratio
69
market cap
57.75 B
div yield
0
usd
Mar 2025
qoq
revenue
3.03 B
-20.07 %
net incoming
809 M
-11.88 %
eps
8.22 %
-31.90 %
eps surprise
-3.03 %
net profit margin
26.70 %
2.00 %
operating incoming
592 M
-40.24 %
net change in cash
604 M
26.57 %
cash on hand
3.09 B
24.19 %
cost of revenue
464 M
-17.88 %
top